Magnolia Medical Technologies has appointed two former Becton Dickinson senior executives to its medical and scientific advisory board. They are Richard Ivey, retired worldwide vice president of research and development for Becton Dickinson's life sciences diagnostic systems business, and Paul Goldenbaum, retired director of research and development for BD's diagnostic instrument systems division.
With BD, Ivey led an R&D team of several hundred engineers and scientists focused on diagnostic technologies, including infectious disease diagnostic instrumentation, laboratory automation engineering, microbiology, molecular biology, immunochemistry, and cytology.
With BD, Goldenbaum was charged with improving and expanding the Bactec blood culture media product line for sepsis testing. In this role, he developed the blood culture media for all generations of the Bactec blood culture system including radiometric, resin media, non-radiometric, and the current fluorescent, non-invasive media.